1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Microbot Medical Acquires CardioSert - Novel Technology

M&A Deal Summary

Microbot Medical Acquires CardioSert - Novel Technology

On May 25, 2018, Microbot Medical acquired information technology company CardioSert - Novel Technology from CardioSert

Acquisition Highlights
  • This is Microbot Medical’s 1st transaction in the Information Technology sector.
  • This is Microbot Medical’s 1st transaction in the United States.

M&A Deal Summary
Date 2018-05-25
Target CardioSert - Novel Technology
Sector Information Technology
Buyer(s) Microbot Medical
Sellers(s) CardioSert
Deal Type Divestiture

Target

CardioSert - Novel Technology

United States
CardioSert Ltd. - Novel Technology is a provider of patent-protected technology.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Microbot Medical

Hingham, Massachusetts, United States
Category Company
Sector Medical Products
DESCRIPTION

Microbot Medical, Inc. is specialized in the researching, designing, developing and commercializing of transformational micro-robotics medical technologies. Microbot Medical is based in Hingham, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1

Seller(S) 1

SELLER

CardioSert

United States
Category Company
Sector Medical Products
DESCRIPTION

CardioSert Ltd. is a developer of medical tools to support interventional cardiologists in percutaneous coronary intervention (PCI) procedures.

DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal